🇺🇸 FDA
Patent

US 10610497

Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

granted A61KA61K31/137A61K47/10

Quick answer

US patent 10610497 (Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse) held by Acurx Pharmaceuticals, Inc. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/137, A61K47/10, A61K47/12, A61K47/14